Literature DB >> 2462466

Auto-tumor recognition following in vitro induction of MHC antigen expression on solid human tumors: stimulation of lymphocytes and generation of cytotoxicity against the original MHC-antigen-negative tumor cells.

F Vánky1, G Stuber, S Rotstein, E Klein.   

Abstract

Expression of major histocompatibility complex (MHC) class I antigens was induced in eight out of nine freshly prepared tumor cell suspensions by exposure to interferon (IFN gamma) and tumor necrosis factor (TNF alpha) in vitro. The untreated, class-I-antigen-negative, and the treated, antigen-positive, cells of three tumors (one breast carcinoma, one plasmocytoma and one ovarian carcinoma) were compared for the capacity to stimulate autologous and allogeneic blood lymphocytes, to generate auto-tumor cytotoxicity and for sensitivity to the lytic effect induced in autologous mixed lymphocyte tumor cell culture (MLTC). The MHC class I-negative cells did not stimulate, while the cells induced for expression of antigens did. On the other hand, when the autologous cytotoxic cells were generated in the MLTC by the class I antigen-positive tumor cells the class I-negative tumor cells were also damaged. Lysis of the class-I-positive tumor cells was abrogated by the W6/32 monoclonal antibody directed against the monomorphic part of the class I molecules.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2462466     DOI: 10.1007/bf00205795

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  33 in total

1.  Demonstration at the single-cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets.

Authors:  R S Accolla; R P Sekaly; A P McDonald; G Corte; N Gross; S Carrel
Journal:  Eur J Immunol       Date:  1982-02       Impact factor: 5.532

2.  Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells.

Authors:  M Fellous; U Nir; D Wallach; G Merlin; M Rubinstein; M Revel
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

3.  Phenotypic dynamics of tumor progression in human malignant melanoma.

Authors:  E B Bröcker; L Suter; J Brüggen; D J Ruiter; E Macher; C Sorg
Journal:  Int J Cancer       Date:  1985-07-15       Impact factor: 7.396

4.  Immunohistologic characterization of major histocompatibility antigens and inflammatory cellular infiltrate in human breast cancer.

Authors:  A K Bhan; C L DesMarais
Journal:  J Natl Cancer Inst       Date:  1983-09       Impact factor: 13.506

5.  Expression of histocompatibility antigens and characterization of mononuclear cell infiltrates in normal and neoplastic colorectal tissues of humans.

Authors:  H C Umpleby; D Heinemann; M O Symes; R C Williamson
Journal:  J Natl Cancer Inst       Date:  1985-06       Impact factor: 13.506

6.  Lysis of autologous tumor cells by blood lymphocytes tested at the time of surgery. Correlation with the postsurgical clinical course.

Authors:  F Vánky; E Klein; J Willems; K Böök; T Ivert; A Péterffy; U Nilsonne; A Kreicbergs; T Aparisi
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

7.  Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.

Authors:  S E Kabawat; R C Bast; W R Welch; R C Knapp; A K Bhan
Journal:  Int J Cancer       Date:  1983-11-15       Impact factor: 7.396

8.  Regulation of HLA-DR gene by IFN-gamma. Transcriptional and post-transcriptional control.

Authors:  F M Rosa; M Fellous
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

9.  Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

Authors:  S Carrel; A Schmidt-Kessen; L Giuffrè
Journal:  Eur J Immunol       Date:  1985-02       Impact factor: 5.532

10.  Expression of histocompatibility antigens and characterisation of mononuclear cell infiltrates in human renal cell carcinomas.

Authors:  D Heinemann; P J Smith; M O Symes
Journal:  Br J Cancer       Date:  1987-10       Impact factor: 7.640

View more
  11 in total

1.  Potentiation of the efficacy of murine L1210 leukemia vaccine by a novel immunostimulator 7-thia-8-oxoguanosine: increased survival after immunization with vaccine plus 7-thia-8-oxoguanosine.

Authors:  B S Sharma; L Balazs; A Jin; J C Wang; W B Jolley; R K Robins
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Killer cells induced by stimulation with allogeneic tumor cells and subsequent culture with recombinant interleukin-2.

Authors:  T Fukiage; H Murakami; M Eura; T Ikawa; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

3.  Auto-tumor lysis by blood lymphocytes in vitro. Strongly activated lymphocytes lack selectivity.

Authors:  F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  The polysaccharide K (PSK) potentiates in vitro activation of the cytotoxic function in human blood lymphocytes by autologous tumour cells.

Authors:  F Vánky; P Wang; E Klein
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  Application of isoelectric focusing for studies of major histocompatibility complex class I antigen expression on human carcinomas and sarcomas.

Authors:  P Wang; F Vánky; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Cytotoxic susceptibility and defective MHC class I expression do not correlate with mutation of p53 in human carcinomas.

Authors:  Z Végh; P Wang; F Vánky; C Hising; K Sjöwall; B Larsson; E Klein
Journal:  Cancer Immunol Immunother       Date:  1994-01       Impact factor: 6.968

7.  The role of major histocompatibility complex expression on head and neck cancer cells in the induction of autologous cytotoxic T lymphocytes.

Authors:  K Chikamatsu; M Eura; H Matsuoka; H Murakami; T Fukiage; T Ishikawa
Journal:  Cancer Immunol Immunother       Date:  1994-06       Impact factor: 6.968

8.  Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy.

Authors:  J Kan-Mitchell; X Q Huang; L Steinman; J R Oksenberg; W Harel; J W Parker; P S Goedegebuure; T L Darrow; M S Mitchell
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

9.  Detection of melanoma-reactive CD4+ HLA-class I-restricted cytotoxic T cell clones with long-term assay and pretreatment of targets with interferon-gamma.

Authors:  L G LeMay; J Kan-Mitchell; P Goedegebuure; W Harel; M S Mitchell
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

10.  Expression of the adhesion molecule ICAM-1 and major histocompatibility complex class I antigens on human tumor cells is required for their interaction with autologous lymphocytes in vitro.

Authors:  F Vánky; P Wang; M Patarroyo; E Klein
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.